Julie Gould

Articles by Julie Gould

Luspatercept Outcomes Superior to Epoetin Alfa for Lower-Risk MDS Anemia

Julie GouldMDS | October 29, 2024

The COMMANDS trial data underscore luspatercept as the preferred treatment for disease not previously exposed to ESAs.